Novartis agreed to sell its nearly one-third stake in fellow Swiss drugmaker Roche back to the company for around $20.7 billion.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,